Return to search results
Mesna injection
Mesna Injection is a prescription medication used to protect the bladder from damage caused by certain chemotherapy drugs like ifosfamide or cyclophosphamide. It is administered intravenously as a 100 mg/mL solution by Gland Pharma Limited. This generic drug helps prevent urinary side effects during cancer treatment. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Mesna Injection is a prescription medication used to protect the bladder from damage caused by certain chemotherapy drugs like ifosfamide or cyclophosphamide. It is administered intravenously as a 100 mg/mL solution by Gland Pharma Limited. This generic drug helps prevent urinary side effects during cancer treatment. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Mesna injection",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Mesna injection — ANDA 206992 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206992"
}
]
|
| identifier | ANDA206992 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"health-care",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Mesna injection |
